ARYA Sciences Acquisition Corp IV
ARYD · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.21 | -1.30 | -0.00 | 0.00 |
| FCF Yield | -0.68% | -0.25% | -0.65% | 0.00% |
| EV / EBITDA | -22.95 | -192.09 | 3,122.33 | -15,772.30 |
| Quality | ||||
| ROIC | -15.59% | -0.69% | -4.58% | 100.01% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.34 | -0.45 | 0.16 | -57.19 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | -49.60% | 54.66% | -46,167.41% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -0.45 | -0.03 | -9.58 | -0.83 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |